- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Orchid Pharma Limited — Important, 10-05-2025: Updates
10-05-2025 | 07:48 pm
10-05-2025 | 07:48 pm
Orchid Pharma faces a setback as Allecra Therapeutics GmbH, its licensee for Enmetazobactam commercialization, has filed for insolvency. This could delay or reduce potential revenue from the drug’s market launch, impacting future earnings tied to Enmetazobactam. No financial impact details provided yet.
No comments yet. Be the first to comment!